To explore long non-coding RNA (lncRNA), mRNA and circular RNA (circRNA) expression profiles and their biological functions in the pathogenesis of kidney stones in ethylene glycol-induced urolithiasis rats. The expression of 1440 lncRNAs, 2455 mRNAs and 145 circRNAs was altered in the kidneys of urolithiasis rats. GO and KEGG biological pathway analysis were performed to predict the functions of differentially expressed lncRNAs, circRNAs and co-expressed potential targeting genes. Co-expression networks of lncRNA-mRNA and circRNA-miRNA were constructed based on correlation analysis between differentially expressed RNAs. mRNAs coexpressed with lncRNAs were involved in many kidney diseases, e.g., Ephb6 was associated with the reabsorption ability of the kidney. Arl5b was associated with the dynamic changes in the podocyte foot process in podocyte injury. miRNAs co-expressed with circRNAs, such as rno-miR-138-5p and rno-miR-672-5p, have been proven to be functional in hypercalciuria urolithiasis. The expression profile provided a systematic perspective on the potential functions of lncRNAs and circRNAs in the pathogenesis of kidney stones. Differentially expressed lncRNAs and circRNAs might serve as treatment targets for kidney stones.
30 April 2020 in International Journal Of Clinical Practice
Aim of the study To reveal the risk factors of intraoperative hypotension (IH) and investigate whether IH was corrected in time. Methods used to conduct the study This retrospective cohort study included patients undergoing surgeries in one medical center. We divided all patients into two groups, the IH group and non‐IH group. The clinical features of these two groups were compared and the independent risk factors for IH were analyzed. Results of the study A total of 5864 non‐cardiac surgery patients were included, of which 931 patients had IH diagnose. The independent risk factors of IH include older age, high grade ASA physical status, intrathecal anesthesia, emergency surgery and medical history of hypertension (P<0.01). Among the patients with IH, 44.5% had hypotension lasting between 30 minutes and 120 minutes, and 25.2% had hypotension lasting more than 120 minutes. Patients with IH are more likely to develop major postoperative complications after surgery (p <0.01). Conclusions The independent risk factors of IH include older age, high grade ASA physical status, intrathecal anesthesia, emergency surgery and history of hypertension. Hypotension during surgery is not always effectively treated.
Nephrolithiasis is a frequent chronic urological condition with a high prevalence and recurrence rate. Proteomics studies on urolithiasis rat models are highly important in characterizing the pathophysiology of kidney stones and identifying potential approaches for preventing and treating kidney stones. The isobaric tags for relative and absolute quantification (iTRAQ) were performed to identify differentially expressed proteins (DEPs) in the kidney between urolithiasis rats and control rats. The results showed that 127 DEPs (85 upregulated and 42 downregulated) were identified in urolithiasis and control rats. The functions of DEPs were predicted by Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, and protein–protein interaction (PPI) network analysis. The expression of four upregulated proteins (Tagln, Akr1c9, Spp1, and Fbn1) and four downregulated proteins (Hbb, Epb42, Hmgcs2, and Ca1) were validated by parallel reaction monitoring (PRM). Proteomics studies of ethylene glycol‐induced urolithiasis rat models using iTRAQ and PRM helped to elucidate the molecular mechanism governing nephrolithiasis and to identify candidate proteins for the treatment of kidney stones.
Background: Kidney stone formation is a common disease that causes a significant threat to human health. The crystallization mechanism of calcium oxalate, the most common type of kidney stone, has been extensively researched, yet the damaging effects and mechanisms of calcium oxalate crystals on renal tubular epithelial cells remain incompletely elucidated. Regulated mitochondrial dynamics is essential for eukaryotic cells, but its role in the occurrence and progression of calcium oxalate (CaOx) nephrolithiasis is not yet understood. Methods: An animal model of calcium oxalate-related nephrolithiasis was established in adult male Sprague‒Dawley (SD) rats by continuously administering drinking water containing 1% ethylene glycol for 28 days. The impact of calcium oxalate crystals on mitochondrial dynamics and apoptosis in renal tubular epithelial cells was investigated using HK2 cells in vitro. Blood samples and bilateral kidney tissues were collected for histopathological evaluation and processed for tissue injury, inflammation, fibrosis, oxidative stress detection, and mitochondrial dynamics parameter analysis. Results: Calcium oxalate crystals caused higher levels of mitochondrial fission and apoptosis in renal tubular epithelial cells both in vivo and in vitro. Administration of a PPARγ agonist significantly alleviated mitochondrial fission and apoptosis in renal tubular epithelial cells, and improved renal function, accompanied by reduced levels of oxidative stress, increased antioxidant enzyme expression, alleviation of inflammation, and reduced fibrosis in vivo. Conclusion: Our results indicated that increased mitochondrial fission in renal tubular epithelial cells is a critical component of kidney injury caused by calcium oxalate stones, leading to the accumulation of reactive oxygen species within the tissue and the subsequent initiation of apoptosis. Regulating mitochondrial dynamics represents a promising approach for calcium oxalate nephrolithiasis.
Prostate cancer ranks as the second most prevalent cancer among men, with androgen deprivation therapy (ADT) being a cornerstone treatment strategy. Enzalutamide, apalutamide, and darolutamide are key examples of second-generation androgen receptor antagonists (SGARAs). Although severe cutaneous adverse reactions (SCARs) are infrequent, they carry a significant risk of mortality. This study employed four disproportionality analysis algorithms: Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Multi-item Gamma Poisson Shrinker (MGPS) to investigate the potential link between SGARAs and SCARs. As of the second quarter of 2024, reports of SCARs related to enzalutamide, apalutamide, and darolutamide totaled 25, 77, and 1, respectively. The majority of reports came from elderly patients, predominantly reported by health professionals, with Japan and the USA being the primary reporting countries. SCARs related to apalutamide detected positive signals in all four algorithms, while enzalutamide and darolutamide did not show positive signals. The study indicated that the majority of onset times occurred within 37 days, but SCARs could still occur up to 176 days with enzalutamide and 126 days after apalutamide treatment. No onset time was reported for darolutamide. In the treatment of prostate cancer with SGARAs, there is a potential risk of SCARs. When different SGARAs were compared, SCARs were more frequently reported with apalutamide than enzalutamide and darolutamide. This indicates that patients using SGARAs, particularly apalutamide, require closer and more prolonged monitoring to facilitate the early detection and management of SCARs and to reduce the occurrence of serious outcomes.
Kidney stones are increasingly common globally, and drug-induced kidney stones are often under-recognized. Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used, and their potential link to kidney stones is an area of concern. The aim of this study is to explore the potential relationship between NSAIDs and kidney stones using Mendelian randomization (MR). NSAIDs target genes were identified, and expression quantitative trait locus data were used to find genetic instruments. We conducted a summary data-based MR analysis to verify associations between genetic instruments and inflammatory factors and then assessed the causal relationship between target gene expressions and kidney stones. Sensitivity analyses, including colocalization analysis, horizontal pleiotropy assessment, investigation of weak instrumental variable impact, use of multiple data sources and methods, and testing of associations between inflammatory factors and kidney stone risk, were performed. Twelve target genes were identified. After comprehensive analysis, only NEU1 showed a significant genetically proxied association with kidney stone risk. A decrease in genetically proxied NEU1 expression was associated with an increased risk of kidney stones (odds ratio = 0.6, 95% CI 0.47-0.77). Sensitivity analyses supported the reliability of this association. No significant association was observed between tumour necrosis factor-alpha (TNF-α) and kidney stones, suggesting that the NEU1-kidney stone association may be independent of TNF-α. Genetically proxied lower NEU1 expression was associated with higher kidney stone risk. This association appeared independent of TNF-α levels. These findings warrant further mechanistic studies to investigate NEU1-related pathways in nephrolithiasis.